What is PRGO's market cap?

$2.20B, based on the Nov 4 close of $15.83.

Does PERRIGO pay a dividend?

Yes. The latest regular dividend was $0.29 per share (ex-date Aug 28), an annualised yield of 7.33%.

How much of PRGO is sold short?

24.2M shares, 17.5% of float, as of Oct 15, 2026.

What sector is PRGO in?

Healthcare, in the Pharmaceuticals industry.

NYSE · PRGOHealthcarePharmaceuticals

PERRIGO COMPANY PLC (PRGO)

$15.83+0.83%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$16.38▼ 20.24% in range

Nov 3, 2025Low $9.25 · High $20.53Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

PERRIGO closed at $15.83 on Nov 4, up 0.83%, 22.9% below its 52-week closing high. Volume of 5.0M shares was 2.04× its 20-day average (well above normal).

Split-adjusted performance: +13.1% over one month, +29.1% over six months, -22.9% over one year.

In the quarter ended Jun 27, 2026, revenue was $1.02B, down 3.2% from a year earlier, with a net margin of 7.3%.

Short interest was 24.2M shares at the Oct 15 settlement (17.5% of float, 9.0 days to cover).

Market cap$2.20B138.8M shares

Revenue · quarter$1.02B−3.2% YoY

Diluted EPS$0.53—

P/E · TTM—P/S 0.5×

Net margin7.3%Gross 30.7%

Dividend yield7.33%$0.29 last paid

52-week range9.25 – 20.53−22.9% from high

Volume5.0M2.04× 20-day avg

Volatility · 60d40.1%Annualised

Short % of float17.5%9.0 days to cover

Net cash-$2.90BCash $399.7M

Next earnings—Not scheduled

Split-adjusted performance

1W −0.6%1M +13.1%3M +26.2%6M +29.1%YTD +13.7%1Y −22.9%3Y −41.6%5Y −64.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum86

Revenue growth38

Net margin76

Value (low P/E)—

Size82

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short24.2M−0.3% vs prior

Days to cover9.0Settled Oct 15

% of float17.5%

Short vol. 10d69.7%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
PRGOPERRIGO	$15.83	+0.83%	+29.1%	−3.2%	7.3%	—	$2.20B
ZYMEZymeworks	$30.94	+2.69%	+12.1%	−90.6%	−980.8%	—	$2.22B	Compare
TRLVTrulieve Cannabis	$11.60	+0.52%	—	—	−149.8%	—	$2.23B	Compare
SEPNSepterna	$47.88	+9.57%	+93.8%	+22375.6%	−48.7%	—	$2.23B	Compare
SDGRSchrodinger	$28.52	+4.93%	+119.7%	+7.5%	10.1%	—	$2.13B	Compare
AUPHAurinia Pharmaceuticals	$17.11	+3.32%	+5.3%	+13.9%	37.9%	7.3	$2.29B	Compare
BHVNBiohaven	$15.24	−2.37%	+51.8%	—	—	—	$2.30B	Compare
IMNMImmunome	$19.52	−3.89%	−16.1%	−100.0%	—	—	$2.30B	Compare
VERAVera Therapeutics	$31.97	+4.10%	−12.6%	—	—	—	$2.30B	Compare

News about PERRIGO

All news →

Perrigo (PRGO) Surpasses Q3 Earnings EstimatesZacks Investment Research · 19h ago▼ Negative Earnings Preview: Perrigo (PRGO) Q3 Earnings Expected to DeclineZacks Investment Research · Oct 28, 2026▼ Negative Perrigo Announces Quarterly DividendBenzinga · Apr 29, 2026▲ Positive Good Start® | Dr. Brown's™ Infant Formulas Receive “Baby Food Product of the Year” In Fifth Annual Baby Innovation AwardsGlobeNewswire Inc. · Mar 3, 2026▲ Positive

Quick answers

What does PERRIGO do?: Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS.
What is PRGO's market cap?: $2.20B, based on the Nov 4 close of $15.83.
Does PERRIGO pay a dividend?: Yes. The latest regular dividend was $0.29 per share (ex-date Aug 28), an annualised yield of 7.33%.
How much of PRGO is sold short?: 24.2M shares, 17.5% of float, as of Oct 15, 2026.
What sector is PRGO in?: Healthcare, in the Pharmaceuticals industry.

About PERRIGO

Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

HQ: Dublin 2, L28,100 employeesListed Dec 16, 1991perrigo.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology